08/14/2025
11:12 AM | Karyopharm Therapeutics (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
| Form SCHEDULE 13G | |
08/11/2025
7:01 AM | Karyopharm Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/11/2025
6:31 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2025
6:34 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2025
3:56 PM | Karyopharm Therapeutics (Issuer)
Poulton Stuart (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2025
4:18 PM | Abate Kristin (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2025
8:34 AM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Karyopharm Therapeutics (Subject)
| Form SCHEDULE 13G | |
07/11/2025
6:28 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2025
3:28 PM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2025
3:12 PM | Karyopharm Therapeutics (Issuer)
Oliger Christy J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2025
3:13 PM | Karyopharm Therapeutics (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for KPTI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Karyopharm Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/29/2025
3:15 PM | Karyopharm Therapeutics (Issuer)
Su Zhen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2025
3:40 PM | Karyopharm Therapeutics (Issuer)
Rangwala Reshma (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/14/2025
7:24 AM | Karyopharm Therapeutics (Filer)
| Form ARS | |
04/14/2025
7:15 AM | Karyopharm Therapeutics (Filer)
| Form DEF 14A | |
04/14/2025
7:19 AM | Karyopharm Therapeutics (Filer)
| Form DEFA14A | |
04/10/2025
4:23 PM | Affinity Asset Advisors, LLC (Filed by)
Karyopharm Therapeutics (Subject)
| Form SCHEDULE 13G | |
03/06/2025
3:13 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:48 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:49 PM | Abate Kristin (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:46 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
6:32 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
6:36 AM | Karyopharm Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/12/2025
8:36 AM | Adage Capital Management, L.P. (Filed by)
Karyopharm Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/05/2025
3:16 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
7:34 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:03 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:07 PM | Karyopharm Therapeutics (Issuer)
Macomber Lori (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
6:08 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:35 PM | Karyopharm Therapeutics (Filer)
| Form PRE 14A | |
12/05/2024
3:15 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
6:09 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
2:50 PM | Karyopharm Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/06/2024
3:06 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
7:02 AM | Karyopharm Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/05/2024
6:47 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
6:41 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
10:49 AM | Karyopharm Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/31/2024
6:41 AM | Karyopharm Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
8:30 AM | HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Karyopharm Therapeutics (Subject)
| Form SC 13G | |
09/05/2024
3:28 PM | Karyopharm Therapeutics (Issuer)
Mano Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Washington prepares for war (Ad) While the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much bigger here at home. Emergency powers are being invoked, trillions are being mobilized, and the scale rivals anything we’ve seen since WWII.
According to Porter Stansberry and Jeff Brown, a new economic arms race is already underway — one that could reshape markets, redirect capital, and impact billions of lives. They’ve just released an urgent briefing that explains what’s really happening behind the scenes, and which companies are positioned to benefit most. Click here now to watch the urgent wartime exposé |
09/05/2024
3:13 PM | Cheng Sohanya Roshan (Reporting)
Karyopharm Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:24 PM | Karyopharm Therapeutics (Issuer)
Mason Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:26 PM | Karyopharm Therapeutics (Issuer)
Paulson Richard A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free KPTI Stock Alerts